PEDIATRICS Vol. 99 No. 5 May 1997, pp. e4 (doi:10.1542/peds.99.5.e4)
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Woolf, A.
Right arrow Articles by Litovitz, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Woolf, A.
Right arrow Articles by Litovitz, T.
Related Collections
Right arrow Therapeutics & Toxicology
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

PEDIATRICS Vol. 99 No. 5 May 1997, p. e4
Copyright ©1997 by the American Academy of Pediatrics

ELECTRONIC ARTICLE:
Childhood Poisoning Involving Transdermal Nicotine Patches

Received Jun 5, 1996; accepted Sep 26, 1996.

Alan Woolf*, Dagger , Keith Burkhart§, Dagger , Thomas Caracciopar , Dagger , and Toby Litovitz, Dagger

From the * Department of Pediatrics, Harvard Medical School, Boston, Massachusetts; Department of Medicine, Children's Hospital, Boston, Massachusetts; Massachusetts Poison Control System, Boston, Massachusetts; Dagger  American Association of Poison Control Centers; § Central Pennsylvania Poison Center, University Hospital, Milton S. Hershey Medical Center, The Pennsylvania State University, Hershey, Pennsylvania; par  Long Island Regional Poison Control Center, Winthrop University Hospital, Mineola, New York; and the  National Capital Poison Center, Washington, DC.

Objective.  To describe the circumstances, medical complications, and outcomes of children exposed to a transdermal nicotine patch (TNP).

Design.  Prospective case series; postmarketing surveillance study over a 24-month period.

Setting.  Thirty-four United States poison centers.

Patients.  Children 0 to 15 years old exposed to a TNP.

Interventions.  None.

Outcome Measures.  Exposure circumstances, symptoms and signs of toxicity, complications, disposition, and hospital length of stay.

Results.  Reports were received concerning 36 exposures to TNP in children younger than 16 years old (mean: 3 years old). Eighteen of these TNP exposures were dermal; 18 additional children had bitten, chewed, or swallowed part of a patch. All four commercial brands of TNP were represented; no brand was associated with more symptoms or an increased severity of illness. Fourteen children (39%) developed symptoms, including gastrointestinal distress (nausea, vomiting, diarrhea, abdominal pain), weakness, dizziness, or localized rashes. Occurrence of symptoms after a dermal exposure to a TNP was associated with an estimated nicotine dose >= .10 mg (>= .01 mg/kg body weight). Ten children were seen in the emergency department; two were admitted overnight. All recovered fully.

Conclusions.  In this series, unintentional exposures to TNPs among young children usually involved used patches, were transient (<20 minutes duration), and required only skin decontamination and supportive care. Continued monitoring of inadvertent childhood exposures to TNPs is recommended to confirm these observations. nicotine, poisoning, transdermal nicotine patch, overdose, pediatric poisoning, intoxication.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?